Major Decisions On How NCI Will Spend Extra Money Won’t Be Made for Three-Four Months
In Brief: Twenty-Nine Percent Of Approved Organ Systems Applications Funded In February, May Cycles
Consensus Conference agrees That Nevi Can Be Precursors For Melanoma, Offers Management Suggestions
DCBD Board Rejects Breast Cancer Multiple Markers Concept Proposal
DRCCA Board Gets Tough on Concept Proposals, Okays Several Anyway
Trending Stories
- Narjust Duma named associate director of the Cancer Care Equity Program at DFCI, Harvard Medical School
- Robert Stone: City of Hope aims to transform cancer care nationally through new models, partnerships
- Biden commits to creating “ARPA-H” research body in visit to Ohio State
- Amy Reed, physician and patient who “moved mountains” to end widespread use of power morcellation, dies at 44
- The Cancer Letter gets a new website
You may have noticed that things are looking different around here - Abecma receives FDA approval for multiple myeloma
